P3 Health Partners Inc. (NASDAQ:PIII) Q1 2023 Earnings Conference Call May 10, 2023 4:30 PM ET Company Participants Karen Blomquist - Vice President, Investor Relations Sherif Abdou - Chief Executive Officer & Co-Founder Atul Kavthekar - Chief Financial Officer Amir Bacchus - Chief Medical Officer Conference Call Participants Brooks O'Neil - Lake Street Capital Markets Ryan Daniels - William Blair Josh Raskin - Nephron Research Gary Taylor - Cowen Operator Good afternoon, everyone, and welcome to the P3 Hea ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-40033 P3 Health Partners Inc. (Exact name of registrant as specified in its charter) Delaware 85-2992794 (State or other jurisdiction of i ...

P3 Health Partners Inc. (NASDAQ:PIII) Q4 2022 Earnings Conference Call March 31, 2023 8:30 AM ET Company Participants Karen Blomquist - Director, IR Sherif Abdou - CEO Atul Kavthekar - CFO Conference Call Participants Brooks O'Neil - Lake Street Capital Markets Joshua Raskin - Nephron Research Operator Good day, and welcome to the P3 Health Partners Fourth Quarter 2022 Earnings Conference Call. All participants will be in listen-only mode. [Operator Instructions] Please note, this event is being recorded. I ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-40033 P3 Health Partners Inc. (Exact name of registrant as specified in its charter) Delaware 85-2992794 (State or other juri ...

P3 Health Partners Inc. (NASDAQ:PIII) Q3 2022 Results Conference Call November 14, 2022 4:30 PM ET Company Participants Karen Blomquist - Vice President of Investor Relations Sherif Abdou - Chief Executive Officer Erin Darakjian - Interim Chief Financial Officer Amir Bacchus - Co-Founder and Chief Medical Officer Conference Call Participants Joshua Raskin - Nephron Research Brooks O'Neil - Lakes Treat Gary Taylor - Cowen Operator Greetings, and welcome to P3 Health Partners Third Quarter 2022 Earnings Confe ...

P3 Health Partners Inc. (NASDAQ:PIII) Q2 2022 Earnings Conference Call October 20, 2022 4:30 PM ET Company Participants Karen Blomquist - Vice President, Investor Relations Sherif Abdou - Chief Executive Officer Eric Atkins - Chief Financial Officer Amir Bacchus - Chief Medical Officer Erin Darakjian - Chief Accounting Officer Conference Call Participants Brooks O'Neil - Lake Street Capital Markets Josh Raskin - Nephron Research Ryan Daniels - William Blair Gary Taylor - Cowen & Company Operator Greetings. ...

P3 Investor Presentation May 2021 Who: People with Passion and Purpose What: Dedicated to Transforming Healthcare for Patients, Providers, and Payors How: Patient-Centric, Physician-Led, and Population Health Management Focused Foresight Acquisition Corp. Is Led By A World Class Management Team With Deep Operational And Investing Expertise | --- | --- | --- | --- | |-------------------------------------------|--------------------------------------------------------------------------------------------------- ...